-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Severity_V2.PDF
January 01, 2019 - Other ear, nose, mouth & throat procedures 15,524 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … & blood-forming organs 104,417 0.58%
680: Major O.R. procedures for lymphatic/hematopoietic/other neoplasms … 9,388 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 12,868 0.07%
690 … Lymphoma, myeloma & non-acute leukemia 26,832 0.15%
692: Radiotherapy 793 0.00%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 16,470 0.09%
695: Chemotherapy for acute leukemia 15,191 0.08%
696
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Severity.PDF
January 01, 2017 - Other ear, nose, mouth & throat procedures 16,344 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … & blood-forming organs 103,525 0.58%
680: Major O.R. procedures for lymphatic/hematopoietic/other neoplasms … 8,897 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 13,201 0.07%
690 … Lymphoma, myeloma & non-acute leukemia 27,774 0.15%
692: Radiotherapy 1,066 0.01%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 16,094 0.09%
695: Chemotherapy for acute leukemia 14,068 0.08%
696
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Severity.PDF
January 01, 2016 - Other ear, nose, mouth & throat procedures 16,236 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … & blood-forming organs 101,570 0.59%
680: Major O.R. procedures for lymphatic/hematopoietic/other neoplasms … APRDRG
APRDRG Frequency
Percent
of Total
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms … Lymphoma, myeloma & non-acute leukemia 23,708 0.14%
692: Radiotherapy 1,231 0.01%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 15,059 0.09%
695: Chemotherapy for acute leukemia 14,600 0.08%
696
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Severity.PDF
January 01, 2017 - Other ear, nose, mouth & throat procedures 6,486 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … blood & blood-forming organs 37,684 0.53%
680: Major O.R. procedures for lymphatic/hematopoietic/other neoplasms … 3,100 0.04%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,773 0.07%
690 … Lymphoma, myeloma & non-acute leukemia 10,255 0.14%
692: Radiotherapy 488 0.01%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 5,704 0.08%
695: Chemotherapy for acute leukemia 5,950 0.08%
please
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
January 01, 2019 - W MCC 97 0.00%
181: RESPIRATORY NEOPLASMS W CC 135 0.00%
182: RESPIRATORY NEOPLASMS W/O CC/MCC 29 … W MCC 37 0.00%
375: DIGESTIVE MALIGNANCY W CC 59 0.00%
376: DIGESTIVE MALIGNANCY W/O CC/MCC 18 0.00% … OF PANCREAS EXCEPT MALIGNANCY W MCC 811 0.03%
439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY W CC 2,006 … FOR NEOPLASM W/O CC/MCC 146 0.00%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 354 0.01% … W MCC 34 0.00%
687: KIDNEY & URINARY TRACT NEOPLASMS W CC 82 0.00%
688: KIDNEY & URINARY TRACT NEOPLASMS
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
June 01, 2020 - kidney failure, liver disease, osteopenia and osteoporosis, neurocognitive deficits, and
secondary malignancies … for CCS is critical to minimize and alleviate disparities due to
the adverse sequelae of their prior malignancy … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan
-
hcup-us.ahrq.gov/reports/methods/2004CCSUserGuideFinal.pdf
September 01, 2004 - malignancies
43 Malignant neoplasm without specification of site
44 Neoplasms of unspecified … [41]
2.12 Secondary malignancies [42]
2.12.1 Secondary malignancy of lymph nodes
2.12.2 … 2.13 Malignant neoplasm without specification of site [43]
2.14 Neoplasms of unspecified nature or … neoplasms
2.16.1 Benign neoplasm of uterus [46]
2.16.2 Other and unspecified benign neoplasm … [47]
2.16.2.1 Benign neoplasm of ovary
2.16.2.2 Benign neoplasm of colon
2.16.2.3 Benign
-
hcup-us.ahrq.gov/db/nation/nrd/Supp-AnalysisICD10Readmissions.xlsx
January 01, 2017 - -4.50 Stable 1,745 11.11 1,612 10.75 -3.27 Stable * * * * * *
658: KIDNEY & URETER PROCEDURES FOR NEOPLASM … Unstable 1,486 26.24 2,265 25.99 -0.96 Stable * * * * * *
660: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … PROC EXC MALIGNANCY W/O CC/MCC * * * * * * * * * * * * * * * *
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM … 10.01 29,428 9.96 -0.53 Stable
17: MYELOPROLIFERATIVE DISEASES & DISORDERS, POORLY DIFFERENTIATED NEOPLASM … PROC EXC MALIGNANCY W/O CC/MCC * * * * * * * * * * * * * * * *
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_IP_MaskedStats.PDF
January 01, 2019 - W MCC 9,103 0.19
181: RESPIRATORY NEOPLASMS W CC 4,667 0.10
182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 79 0.00
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 3,385 0.07 … W MCC 762 0.02
687: KIDNEY & URINARY TRACT NEOPLASMS W CC 1,137 0.02
688: KIDNEY & URINARY TRACT NEOPLASMS … W MCC 9,106 0.19
181: RESPIRATORY NEOPLASMS W CC 4,666 0.10
182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 79 0.00
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 3,389 0.07
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_CORE_V2.PDF
January 01, 2019 - W MCC 25,992 0.14%
181: RESPIRATORY NEOPLASMS W CC 14,990 0.08%
182: RESPIRATORY NEOPLASMS W/O CC/ … W MCC 18,060 0.10%
375: DIGESTIVE MALIGNANCY W CC 21,127 0.12%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 13,034 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … 723: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W CC 2,105 0.01%
724: MALIGNANCY, MALE REPRODUCTIVE SYSTEM … MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC 4,739 0.03%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
January 01, 2017 - W MCC 43,745 0.12%
181: RESPIRATORY NEOPLASMS W CC 29,360 0.08%
182: RESPIRATORY NEOPLASMS W/O CC/ … W MCC 28,315 0.08%
375: DIGESTIVE MALIGNANCY W CC 38,315 0.11%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 22,860 0.06%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … PROC EXC MALIGNANCY W/O CC/MCC 935 0.00%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 2,190 0.01% … : MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC 8,920 0.02%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_V2.PDF
January 01, 2019 - W MCC 9,384 0.13%
181: RESPIRATORY NEOPLASMS W CC 5,275 0.07%
182: RESPIRATORY NEOPLASMS W/O CC/MCC … W MCC 6,494 0.09%
375: DIGESTIVE MALIGNANCY W CC 7,542 0.11%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … OF PANCREAS EXCEPT MALIGNANCY W MCC 10,159 0.14%
439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY W CC … PROCEDURES FOR NEOPLASM W/O CC/MCC 4,589 0.06%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC … PROC EXC MALIGNANCY W/O CC/MCC 447 0.01%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 382 0.01%
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core.PDF
January 01, 2017 - W MCC 23,715 0.13%
181: RESPIRATORY NEOPLASMS W CC 16,964 0.09%
182: RESPIRATORY NEOPLASMS W/O CC/ … W MCC 15,446 0.09%
375: DIGESTIVE MALIGNANCY W CC 21,586 0.12%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 13,096 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … PROC EXC MALIGNANCY
W/O CC/MCC
565 0.00%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 1,187 0.01% … : MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC 5,166 0.03%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core_Weighted.PDF
January 01, 2016 - W MCC 41,029 0.12%
181: RESPIRATORY NEOPLASMS W CC 32,860 0.09%
182: RESPIRATORY NEOPLASMS W/O CC/ … W MCC 23,076 0.06%
375: DIGESTIVE MALIGNANCY W CC 37,072 0.10%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 23,877 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … PROC EXC MALIGNANCY W/O CC/MCC 1,040 0.00%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 1,805 0.01% … : MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC 8,611 0.02%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core.PDF
January 01, 2017 - W MCC 8,749 0.12%
181: RESPIRATORY NEOPLASMS W CC 5,872 0.08%
182: RESPIRATORY NEOPLASMS W/O CC/MCC … W MCC 5,663 0.08%
375: DIGESTIVE MALIGNANCY W CC 7,663 0.11%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … OF PANCREAS EXCEPT MALIGNANCY W MCC 10,025 0.14%
439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY W CC … PROCEDURES FOR NEOPLASM W/O CC/MCC 4,572 0.06%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC … PROC EXC MALIGNANCY W/O CC/MCC 187 0.00%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 438 0.01%
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-1996
January 01, 1996 - FOBT can also miss small adenomas and colorectal malignancies that bleed intermittently or not at all … Distribution of colorectal neoplasms. A left-to-right shift of polyps and cancer. … Screening for colon malignancy with colonoscopy. … Large colonoscopic neoplasms missed by endoscopy. … The incidence of benign and malignant neoplasms of the colon and rectum: a postmortem study.
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core_Weighted.PDF
January 01, 2016 - W MCC 108 0.00%
181: RESPIRATORY NEOPLASMS W CC 173 0.00%
182: RESPIRATORY NEOPLASMS W/O CC/MCC 68 … W MCC <= 50 *.**%
375: DIGESTIVE MALIGNANCY W CC 86 0.00%
376: DIGESTIVE MALIGNANCY W/O CC/MCC 52 … FOR NEOPLASM W/O CC/MCC 272 0.00%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 455 0.01% … PROC EXC MALIGNANCY W/O CC/MCC <= 50 *.**%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC <= 50 *.* … MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC <= 50 *.**%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Core.PDF
January 01, 2013 - W MCC 18,441 0.13%
181: RESPIRATORY NEOPLASMS W CC 19,161 0.13%
182: RESPIRATORY NEOPLASMS W/O CC/ … PROCEDURES FOR NEOPLASM W/O CC/MCC 10,441 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … ; other and unspecified primary 2,948 0.02%
42: Secondary malignancies 87,731 0.61%
43: Malignant neoplasm … 18,883 0.13%
45: Maintenance chemotherapy; radiotherapy 64,579 0.45%
46: Benign neoplasm of uterus … 53,654 0.37%
47: Other and unspecified benign neoplasm 58,035 0.41%
48: Thyroid disorders 15,663 0.11%
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core_Weighted.PDF
January 01, 2007 - non-epithelial cancer of skin 7189 0.02
24: Cancer of breast 95113 0.24
25: Cancer of uterus 41277 … 0.01
31: Cancer of other male genital organs 971 0.00
32: Cancer of bladder 38064 0.10
33: Cancer … ; other and unspecified primary 8458 0.02
42: Secondary malignancies 263493 0.67
43: Malignant neoplasm … 0.13
45: Maintenance chemotherapy; radiotherapy 184550 0.47
46: Benign neoplasm of uterus 210358 0.53 … 47: Other and unspecified benign neoplasm 165472 0.42
48: Thyroid disorders 46283 0.12
49: Diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
October 29, 2012 - Pediatric Oncologist, Pediatric Medical
Oncology
Memorial Sloan-Kettering Cancer Center
New York … , and high-risk relapsed Wilm’s tumor. … , Germ Cell and Embryonal"/ (256042)
33 ("germ cell tumor*" or "germ cell cancer" or "germ cell … / (617)
73 ("choroid plexus" and (tumor or tumour or tumors or tumours or neoplasm*)).mp. (1944) … , and high-risk
relapsed Wilm’s tumor.